In hypercortisolism patients, PDE2A mRNA and PDE2A protein levels have been found to be upregulated in adrenocortical tumors harboring CTNNB1 mutations compared with wild-type adrenocortical tissues [96]. This evidence concerns the gene PDE2A and adrenal gland hyperfunction.